Health
Public Health Patient Care Pharmaceuticals Medical Research Emergency Services Mental Health Cancer Clinical Trials Research NHS
The plan seeks $1.7 billion in annual savings by 2027 to reinvest in its pipeline ahead of Keytruda’s patent expiry